The FDA withdrew its approval of Makena, the only preterm birth drug greenlit by the agency, on April 6 after research showed the treatment did not work better than a placebo.
Read the full post on Becker's Hospital Review - Healthcare News
The FDA withdrew its approval of Makena, the only preterm birth drug greenlit by the agency, on April 6 after research showed the treatment did not work better than a placebo.
Read the full post on Becker's Hospital Review - Healthcare News